Nanomedicines in the treatment of brain tumors

被引：14
作者：
Fisusi, Funmilola A. [1 ,2 ]
Schatzlein, Andreas G. [1 ,3 ]
Uchegbu, Ijeoma F. [1 ,3 ]
机构：
[1] UCL Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England
[2] Obafemi Awolowo Univ, Fac Pharm, Drug Res & Prod Unit, Ife, Nigeria
[3] Nanomerics Ltd, New Bridge St House,30-34 New Bridge St, London EC4V 6BJ, England
来源：
NANOMEDICINE | 2018年 / 13卷 / 06期
基金：
英国工程与自然科学研究理事会;
关键词：
brain tumor; doxorubicin; glioblastoma; nanomedicine; nanoparticle; paclitaxel; theranostic; CORE-SHELL NANOPARTICLES; LONG-TERM SURVIVAL; GLIOBLASTOMA-MULTIFORME; DRUG-DELIVERY; GLIOMA; THERAPY; CANCER; BARRIER; DOXORUBICIN; METASTASES;
D O I：
10.2217/nnm-2017-0378
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：579 / 583
页数：5
相关论文
共 38 条
  • [1] Astrocyte-endothelial interactions at the blood-brain barrier
    Abbott, NJ
    Rönnbäck, L
    Hansson, E
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) : 41 - 53
  • [2] Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma
    Agarwal, Sagar
    Manchanda, Pooja
    Vogelbaum, Michael A.
    Ohlfest, John R.
    Elmquist, William F.
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 33 - 39
  • [3] Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
    Agarwal, Sagar
    Sane, Ramola
    Oberoi, Rajneet
    Ohlfest, John R.
    Elmquist, William F.
    [J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2011, 13 : e17
  • [4] Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
    Agemy, Lilach
    Friedmann-Morvinski, Dinorah
    Kotamraju, Venkata Ramana
    Roth, Lise
    Sugahara, Kazuki N.
    Girard, Olivier M.
    Mattrey, Robert F.
    Verma, Inder M.
    Ruoslahti, Erkki
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (42) : 17450 - 17455
  • [5] Nanoparticles in the clinic
    Anselmo, Aaron C.
    Mitragotri, Samir
    [J]. BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (01) : 10 - 29
  • [6] Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles
    Bhojani, Mahaveer Swaroop
    Van Dort, Marcian
    Rehemtulla, Alnawaz
    Ross, Brian D.
    [J]. MOLECULAR PHARMACEUTICS, 2010, 7 (06) : 1921 - 1929
  • [7] Nanoparticle therapeutics: an emerging treatment modality for cancer
    Davis, Mark E.
    Chen, Zhuo
    Shin, Dong M.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) : 771 - 782
  • [8] Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
    Dhermain, Frederic G.
    Hau, Peter
    Lanfermann, Heinrich
    Jacobs, Andreas H.
    van den Bent, Martin
    [J]. LANCET NEUROLOGY, 2010, 9 (09) : 906 - 920
  • [9] Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
    Drbohlavova, Jana
    Chomoucka, Jana
    Adam, Vojtech
    Ryvolova, Marketa
    Eckschlager, Tomas
    Hubalek, Jaromir
    Kizek, Rene
    [J]. CURRENT DRUG METABOLISM, 2013, 14 (05) : 547 - 564
  • [10] Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments
    Fisusi, Funmilola A.
    Siew, Adeline
    Chooi, Kar Wai
    Okubanjo, Omotunde
    Garrett, Natalie
    Lalatsa, Katerina
    Serrano, Dolores
    Summers, Ian
    Moger, Julian
    Stapleton, Paul
    Satchi-Fainaro, Ronit
    Schatzlein, Andreas G.
    Uchegbu, Ijeoma F.
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (05) : 1289 - 1303
1234